ACD/Labs
Advanced Chemistry Development (ACD/Labs) develops and commercializes informatics solutions for chemical, biochemical and pharmaceutical research and development. Their expertise lies in vendor-agnostic spectroscopic and chromatographic data processing and prediction, physicochemical and absorption, distribution, metabolism, excretion and toxicity (ADME-Tox) property prediction, analytical knowledge management, interactive reporting and integrating analytical data with chemical structures to help protect and leverage valuable research knowledge.
Latest Content
ACD/Labs Announces Version 2025 of Software on Its Spectrus® & Percepta® Platforms
Revvity To Acquire ACD/Labs To Expand Its Signals Software Capabilities
ACD/Labs Announces Katalyst D2D® Software Release With Expanded Capabilities for Accelerated Pharmaceutical Development
ACD/Labs and Covestro Announce Collaboration Delivering AI-Supported Solvent Selection at PhysChem Forum 2025
Redefining Pharmaceutical R&D Through AI and the Digitalized Physical DMTA Cycle
Faster, More Confident Small Molecule Structure Verification in Pharmaceutical R&D
ACD/Labs Releases State-of-the-Industry Report Highlighting Trends in Chemical Structure Elucidation & Verification
ACD/Labs Launches Version 2024 of Spectrus Software for Digitalized, Data-Driven R&D